JPS5842845B2 - honey bee - Google Patents
honey beeInfo
- Publication number
- JPS5842845B2 JPS5842845B2 JP9683774A JP9683774A JPS5842845B2 JP S5842845 B2 JPS5842845 B2 JP S5842845B2 JP 9683774 A JP9683774 A JP 9683774A JP 9683774 A JP9683774 A JP 9683774A JP S5842845 B2 JPS5842845 B2 JP S5842845B2
- Authority
- JP
- Japan
- Prior art keywords
- disease
- rot
- drug
- american
- honey bee
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は蜜蜂のアメリカ腐岨病を予防することのできる
組成物に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a composition capable of preventing American rot in honeybees.
アメリカ腐岨病とはグラム陽性菌Bacillusla
rvaeが原因する細菌性疾病である。What is American rot? Gram-positive bacterium Bacillus
It is a bacterial disease caused by P. rvae.
本病は伝染力が極めて強いうえに、法定伝染病であると
ころから発症が確認されれば、ただちに焼却することが
義務づけられているので、養蜂家に与える被害は犬なる
ものがある。This disease is extremely contagious, and as it is a legally contagious disease, if symptoms are confirmed, it is mandatory to immediately incinerate beekeepers, so the damage it causes to beekeepers is comparable to dogs.
本発明者はこのアメリカ腐岨病について鋭意研究を重ね
た結果、本病の病原菌Bacillus 1arvae
に対して6−メドキシー4−ピリミジニルスルファニル
アミド(以下、スルファモノメトキシンと略す。As a result of intensive research on this American rot disease, the present inventor discovered that the causative agent of this disease, Bacillus 1arvae.
6-medoxy 4-pyrimidinylsulfanilamide (hereinafter abbreviated as sulfamonomethoxine).
)及び2・6−シメトキシー4−ピリミジニルスルファ
ニルアミド(以下、スルファジメトキシンと略す。) and 2,6-cymethoxy4-pyrimidinylsulfanilamide (hereinafter abbreviated as sulfadimethoxine).
)が、他のサルファ剤より数倍強力な抗菌作用を有する
ことを発見し、上記薬剤を投与することにより本病を完
全に防除し、投薬後も病原菌が検出されないことを確認
し、本発明を完成した。) was found to have an antibacterial effect several times stronger than other sulfa drugs, and it was confirmed that this disease could be completely controlled by administering the above drug, and that no pathogenic bacteria was detected even after administration, and the present invention was developed. completed.
本発明を更に詳細に説明する。The present invention will be explained in more detail.
本則の投薬方法としては、水・砂糖・蜜等の水溶液1リ
ツトルあたりスルファモノメトキシンナトリウムあるい
はスルファジメトキシンナトリウムとして、200〜5
00ミリグラムを溶解し、給餌器を用いて1週間に1〜
2回投与し、これを毎週連続的あるいは間歇的に投薬す
る。The basic dosage method is 200 to 50% sulfamonomethoxine sodium or sulfadimethoxine sodium per liter of aqueous solution such as water, sugar, honey, etc.
Dissolve 00 mg and feed from 1 to 100 mg per week using a feeder.
The drug is administered twice, either continuously or intermittently every week.
また、・・ケか噴霧器を用いて巣牌面に直接塗布または
噴霧する等の方法により上記と同様にして投薬する。Also, administer the drug in the same manner as above by directly applying or spraying it on the surface of the nest tiles using a sprayer.
なお、本則を上記方法で投薬しても蜜蜂には全く悪影響
を与えず、蜜中への薬剤の残留もほとんど認められない
ので、公衆衛生上例ら問題をもたらすものでない。Furthermore, even if the drug is administered according to the above-mentioned method, it will not have any adverse effect on bees, and almost no drug will remain in the honey, so it will not cause any problems in terms of public health.
以下にスルファモノメトキシンナトリウムおよびスルフ
ァジメトキシンナトリウムのBacilluslarv
ae に対する抗菌力およびアメリカ腐岨病予防実施例
について述べる。Below are Bacillus larv of sulfamonomethoxine sodium and sulfadimethoxine sodium.
The antibacterial activity against A. ae and examples of prevention of American rot disease will be described.
参考例 1
アメリカ腐岨病の原因菌B 、 1arvaeに対する
サルファ剤の抗菌力の比較
実施例 1
給餌器を使用して薬剤を投薬した場合。Reference Example 1 Comparison of the antibacterial activity of sulfa drugs against the causative bacteria B and 1arvae of American rot disease Example 1 When the drug was administered using a feeder.
実験条件 (1) 供試蜜蜂群数 毎年必ず発症する養蜂場を対象に1区5 として計300群に供試した。Experimental conditions (1) Number of test bee colonies 1 district 5 targeting bee farms where the disease always occurs every year A total of 300 groups were tested.
(2)実験期間
0群
*′ 昭和48年9月〜昭和49年3月
(3)実験方法
砂糖液(温湯1tに砂糖1kg)中に各薬剤を一定量溶
解し、給餌器に1週間に1回2を宛を入れ、5週間連続
投与した。(2) Experimental period: Group 0*' September 1970 - March 1970 (3) Experimental method A fixed amount of each drug was dissolved in sugar solution (1 kg of sugar in 1 ton of warm water) and placed in a feeder for one week. 2 doses were given at a time, and the administration was continued for 5 weeks.
投薬終了後22週間目に腐岨の確認およびB 、 1a
rvaeの検索をした。Confirmation of rot 22 weeks after completion of medication and B, 1a
I searched for rvae.
実施例 2 巣牌に薬剤を噴霧した場合 実験条件 (1) 供試蜜蜂群数 1区30群として計150群に供試した。Example 2 When spraying chemicals on nest tiles Experimental conditions (1) Number of test bee colonies A total of 150 groups were tested, with 30 groups per section.
(2)実験期間
昭和48年1り月〜昭和49年4月
(3)実験方法
水に各薬剤を一定量溶解し、噴霧器を用いて巣牌に1週
間に2回、5週間連続して噴霧投薬した。(2) Experiment period January 1970 - April 1970 (3) Experiment method Dissolve a certain amount of each drug in water and use a sprayer to spray it on the nest tiles twice a week for 5 consecutive weeks. Administered by spray.
投薬終了後18週間目に腐岨の確認およびB、 1ar
vaeの検索を行った。Confirmation of rot 18 weeks after completion of medication and B, 1ar
I searched for vae.
以上の試験結果から、スルファモノメトキシンおよびス
ルファジメトキシンはアメリカ腐岨病の病原菌B、 1
arvaeに対して極めて強い抗菌力を有するとともに
、in vivoにおいても明らかな腐岨病予防効果を
示すことが認められた。From the above test results, sulfamonomethoxine and sulfadimethoxine are the pathogens of American rot disease B, 1.
It was found that it has extremely strong antibacterial activity against S. arvae and also has a clear preventive effect on rot disease in vivo.
Claims (1)
又は2・6−シメトキシー4−ピリミジニルスルファニ
ルアミドを有効成分とすることを特徴とする蜜蜂のアメ
リカ腐岨病の予防剤。1. A prophylactic agent for American rot in honeybees, which comprises 16-medoxy 4-pyrimidinyl sulfanilamide or 2,6-cymethoxy 4-pyrimidinyl sulfanilamide as an active ingredient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9683774A JPS5842845B2 (en) | 1974-08-23 | 1974-08-23 | honey bee |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9683774A JPS5842845B2 (en) | 1974-08-23 | 1974-08-23 | honey bee |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5126232A JPS5126232A (en) | 1976-03-04 |
| JPS5842845B2 true JPS5842845B2 (en) | 1983-09-22 |
Family
ID=14175626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9683774A Expired JPS5842845B2 (en) | 1974-08-23 | 1974-08-23 | honey bee |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5842845B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU77364A1 (en) * | 1977-05-18 | 1979-01-19 |
-
1974
- 1974-08-23 JP JP9683774A patent/JPS5842845B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5126232A (en) | 1976-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69322896T2 (en) | Use of proteins from the transferrin / lactoferrin family to stimulate the immune system | |
| FR11C0017I2 (en) | Use of spinosad or a formulation comprising spinosad | |
| Mutinelli | Practical application of antibacterial drugs for the control of honey bee diseases | |
| RU2759726C2 (en) | Dexmedetomidine or medetomidine for use in the treatment of separation anxiety in dogs | |
| RU2107502C1 (en) | Iodine monochloride, veterinary preparation possessing wide range of action | |
| JP3731983B2 (en) | Drugs for improving night noise in dementia dogs | |
| US5021424A (en) | Vitamin composition for treatment of flea infestation in animals | |
| JPS5842845B2 (en) | honey bee | |
| DE69400188T2 (en) | Veterinary tablet especially for cats | |
| DE69227899T2 (en) | USE OF A BENZIMIDAZOLE WORM FOR TREATING MICROSPORE INFECTIONS | |
| US4005211A (en) | Lactation stimulation employing pimozide | |
| JP2015523388A (en) | Single-dose oral formulations and methods for treating cats with the ectoparasite eradication agent spinosad | |
| EP0402208B1 (en) | Mixture of Vitamin A in physiological dosis and different active ingredients having therapeutic effect | |
| US6110971A (en) | Fungicide composition comprising a benzoylphenylurea | |
| JPH07503949A (en) | Pharmaceutical preparations consisting of clavulanate and erythromycin derivatives | |
| DE3785953T2 (en) | Mixtures that kill bacteria. | |
| US20230413818A1 (en) | Feed and methods for controlling tick infestations in a mammal | |
| ES2105643T3 (en) | USE OF 2- (4- (4-CHLOROFENIL) CICLOHEXIL) -3-HIDROXI-1,4-NAFTOQUINONE FOR THE TREATMENT OF CANCER. | |
| DE2221281C3 (en) | Pharmaceutical preparations with anti-inflammatory and analgesic effects | |
| EP0623344A1 (en) | Use of Selegiline in vetenary medicine | |
| RU2223756C1 (en) | Method for treating equine relapsing iridocyclochorioiditis | |
| Somasundaram et al. | Therapeutic Management of Cutaneous Form of Pigeon Pox in Coimbatore District of Tamil Nadu | |
| DE2532180C2 (en) | Use of Etozolin in the fight against hypertension | |
| RU2228742C2 (en) | Method for treating relapsing equine iridocyclochorioiditis | |
| US20220257610A1 (en) | Enhancing drug activity through accentuated buccal/sublingual administration. |